These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33737384)

  • 1. Identification and characterization of conserved noncoding
    Shao Y; Bajikar SS; Tirumala HP; Gutierrez MC; Wythe JD; Zoghbi HY
    Genes Dev; 2021 Apr; 35(7-8):489-494. PubMed ID: 33737384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of conserved cis-regulatory elements in the post-transcriptional regulation of the human MECP2 gene involved in autism.
    Bagga JS; D'Antonio LA
    Hum Genomics; 2013 Sep; 7(1):19. PubMed ID: 24040966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
    Heckman LD; Chahrour MH; Zoghbi HY
    Elife; 2014 Jun; 3():. PubMed ID: 24970834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
    Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
    Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.
    Vermudez SAD; Buch A; Weiss K; Gogliotti RG; Niswender CM
    Neuropharmacology; 2022 May; 209():109022. PubMed ID: 35248529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cis-regulatory elements for MECP2 expression.
    Liu J; Francke U
    Hum Mol Genet; 2006 Jun; 15(11):1769-82. PubMed ID: 16613900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular pathology of Rett syndrome: synopsis and update.
    Akbarian S; Jiang Y; Laforet G
    Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
    Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
    Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies.
    Sandweiss AJ; Brandt VL; Zoghbi HY
    Lancet Neurol; 2020 Aug; 19(8):689-698. PubMed ID: 32702338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECP2 disorders: from the clinic to mice and back.
    Lombardi LM; Baker SA; Zoghbi HY
    J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare MeCP2_e1 mutation first described in a male patient with severe neonatal encephalopathy.
    Soffer OD; Sidlow R
    Am J Med Genet A; 2016 Jul; 170(7):1881-3. PubMed ID: 27090848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
    Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
    PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pascual-Alonso A; Martínez-Monseny AF; Xiol C; Armstrong J
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.
    Ta D; Downs J; Baynam G; Wilson A; Richmond P; Leonard H
    Orphanet J Rare Dis; 2022 Mar; 17(1):131. PubMed ID: 35313898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
    Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.